Clomid (Clomiphene Citrate)
Prescription fertility medicine for women; men use it off-label to raise testosterone, and it can cause mood problems.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Related comparisons
Nolvadex vs Clomid vs EnclomipheneDETAILED OVERVIEW
What is Clomid (Clomiphene Citrate)?
Clomid (clomiphene citrate) is a prescription medicine approved in the United States in 1967 for female infertility caused by problems with ovulation; it is also registered in Hungary and Poland. In men it is used off-label for low testosterone and, after stopping anabolic steroids, to restart the body's own hormone production.
Its active ingredient is a mix of two components with opposite effects. One blocks the estrogen signal in the pituitary gland, so the gland releases more of the hormones that stimulate the testicles, and testosterone and sperm production start up. The other acts as a weak estrogen, builds up slowly and is behind the mood side effects: about 40–50% of users get mild to moderate low mood or emotional swings. Vision problems can also occur; they usually go away after stopping but are rarely permanent. It must not be used in pregnancy, because it can harm the baby. In competitive sport it is banned for men, both in and out of competition.
Mechanism
Non-steroidal SERM, racemic mixture (62% zuclo + 38% enclo)
Half-life
Zuclomiphene ~5-7 weeks accumulating / enclomiphene ~5 days
Onset
LH rise 5-10 days, Test recovery 3-4 weeks
Legal status
FDA + EMA Rx (female indication), off-label male hypogonadism, WADA S4 (banned)
No anecdote collected yet.
Data console
Lab data
Wu YC, Sung WW . Clomiphene Citrate Treatment as an Alternative Therapeutic Approach for Male Hypogonadism: Mechanisms and Clinical Implications.. Pharmaceuticals (Basel).
Katz DJ, Nabulsi O, Tal R, Mulhall JP . Outcomes of clomiphene citrate treatment in young hypogonadal men.. BJU Int.
Wiehle RD, Fontenot GK, Wike J, Hsu K, Nieschlag E, Saadabadi A . Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone.. Fertil Steril.
Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED . Anabolic steroid-induced hypogonadism: diagnosis and treatment.. Fertil Steril.
Earl JA, Kim ED . Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism.. Expert Rev Endocrinol Metab.
Safety
Side effects, stop signs, contraindications
Side effects · 7
- Mood disturbance: emotional lability, depressed mood, irritability, tearfulness (driven by the zuclomiphene isomer's central nervous-system estrogen-receptor agonism, mild-to-moderate in roughly 40-50% of users).
- Visual disturbances: scintillating scotoma, blurred vision, light sensitivity, afterimages. Usually dose-dependent (chronic >100 mg/day) and reversible on discontinuation, but persistent visual impairment is reported in rare cases.
- Estradiol elevation (E2 rebound): increased testicular estradiol production via raised LH, plus the weak intrinsic estrogenic activity of zuclomiphene. Can cause water retention, gynecomastia flare-ups and headache; more pronounced than with Nolvadex.
- Headache, nausea, hot flushes and dizziness: common estrogen-receptor-modulator side effects, generally mild and dose-dependent.
- Mild rise in blood glucose (fasting glucose) via an indirect metabolic effect of zuclomiphene; warrants extra monitoring in diabetes or prediabetes.
- Ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy with female ovulation-induction use: abdominal distension, enlarged ovaries and, in severe cases, fluid accumulation (not relevant to male PCT use).
- Rare cholestasis and liver-enzyme elevation: documented as a rare event in fertility trials; it is not 17-alpha-alkylated, so overall hepatotoxicity is low.
Contraindications · 7
- Pregnancy (Category X): clomiphene can cause fetal harm and is strictly contraindicated during pregnancy; pregnancy must be excluded before treatment in women.
- Psychiatric history (major depression, bipolar disorder, severe anxiety): the mood lability and depressive effect can trigger or worsen the condition, so it is contraindicated or requires close psychiatric supervision.
- Active liver disease or hepatic dysfunction: a relative contraindication due to hepatic metabolism and the rare cholestasis risk; avoid in liver disease.
- Pre-existing visual disturbance: clomiphene can cause visual-field and vision complaints, so treatment is contraindicated or should be started only under ophthalmologic monitoring if a visual disturbance is present.
- Undiagnosed abnormal uterine bleeding or estrogen-dependent tumor (e.g. history of ovarian tumor): must be excluded before treatment, as hormonal stimulation may worsen it.
- Untreated thyroid or adrenal dysfunction, or pituitary tumor: these must be diagnosed and treated before starting, as they distort the HPTA-axis response.
- Competitive sport: listed on the WADA prohibited list (S4.3 estrogen-receptor modulator), banned both in- and out-of-competition for male athletes.
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
Clomiphene Citrate Treatment as an Alternative Therapeutic Approach for Male Hypogonadism: Mechanisms and Clinical Implications.
Wu YC, Sung WW
Outcomes of clomiphene citrate treatment in young hypogonadal men.
Katz DJ, Nabulsi O, Tal R, Mulhall JP
Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone.
Wiehle RD, Fontenot GK, Wike J, Hsu K, Nieschlag E, Saadabadi A
Anabolic steroid-induced hypogonadism: diagnosis and treatment.
Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED
Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism.
Earl JA, Kim ED
Telegram
Have a question about Clomid (Clomiphene Citrate)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.


